Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 4
1946 11
1947 20
1948 12
1949 19
1950 30
1951 44
1952 33
1953 40
1954 32
1955 38
1956 36
1957 36
1958 33
1959 54
1960 49
1961 36
1962 42
1963 39
1964 59
1965 44
1966 14
1967 16
1968 19
1969 17
1970 28
1971 30
1972 34
1973 104
1974 436
1975 620
1976 521
1977 497
1978 492
1979 557
1980 513
1981 613
1982 551
1983 586
1984 575
1985 633
1986 647
1987 543
1988 566
1989 583
1990 645
1991 676
1992 696
1993 683
1994 745
1995 752
1996 803
1997 761
1998 847
1999 927
2000 967
2001 1150
2002 1294
2003 1456
2004 1779
2005 2216
2006 2497
2007 2815
2008 2986
2009 3195
2010 3887
2011 4316
2012 4465
2013 4718
2014 4717
2015 4639
2016 4452
2017 4132
2018 3724
2019 3291
2020 3119
2021 2646
2022 2417
2023 1983
2024 870

Text availability

Article attribute

Article type

Publication date

Search Results

81,420 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for carbowax
Your search for carbomox retrieved no results
The impact of PEGylation on biological therapies.
Veronese FM, Mero A. Veronese FM, et al. BioDrugs. 2008;22(5):315-29. doi: 10.2165/00063030-200822050-00004. BioDrugs. 2008. PMID: 18778113 Review.
The term PEGylation describes the modification of biological molecules by covalent conjugation with polyethylene glycol (PEG), a non-toxic, non-immunogenic polymer, and is used as a strategy to overcome disadvantages associated with some biopharmaceuticals. ...
The term PEGylation describes the modification of biological molecules by covalent conjugation with polyethylene glycol (PEG), a non- …
Pegloticase.
Schlesinger N, Yasothan U, Kirkpatrick P. Schlesinger N, et al. Nat Rev Drug Discov. 2011 Jan;10(1):17-8. doi: 10.1038/nrd3349. Nat Rev Drug Discov. 2011. PMID: 21193861 No abstract available.
PEG-methioninase.
Hoffman RM. Hoffman RM. Adv Exp Med Biol. 2003;519:69-79. doi: 10.1007/0-306-47932-X_5. Adv Exp Med Biol. 2003. PMID: 12675209 Review. No abstract available.
PEG-asparaginase.
Fu CH, Sakamoto KM. Fu CH, et al. Expert Opin Pharmacother. 2007 Aug;8(12):1977-84. doi: 10.1517/14656566.8.12.1977. Expert Opin Pharmacother. 2007. PMID: 17696798 Review.
PEG-asparaginase, a form of Escherichia coli L-asparaginase covalently linked to polyethylene glycol, was rationally synthesized to decrease immunogenicity of the enzyme and prolong its half-life. ...
PEG-asparaginase, a form of Escherichia coli L-asparaginase covalently linked to polyethylene glycol, was rationally synthesized to d …
Near-field electrospinning.
Sun D, Chang C, Li S, Lin L. Sun D, et al. Nano Lett. 2006 Apr;6(4):839-42. doi: 10.1021/nl0602701. Nano Lett. 2006. PMID: 16608294
CDP-870. Celltech/Pfizer.
Rose-John S, Schooltink H. Rose-John S, et al. Curr Opin Investig Drugs. 2003 May;4(5):588-92. Curr Opin Investig Drugs. 2003. PMID: 12833654 Review.
Celltech Group plc (formerly Celltech Chiroscience), in collaboration with Pfizer Inc (formerly Pharmacia Corp), is developing CDP-870, a polyethylene glycol (PEG)ylated anti-TNF antibody fragment, for the potential treatment of certain autoimmune and inflammatory diseases …
Celltech Group plc (formerly Celltech Chiroscience), in collaboration with Pfizer Inc (formerly Pharmacia Corp), is developing CDP-870, a …
Pegaspargase (Oncaspar).
Ettinger AR. Ettinger AR. J Pediatr Oncol Nurs. 1995 Jan;12(1):46-8. doi: 10.1177/104345429501200110. J Pediatr Oncol Nurs. 1995. PMID: 7893462 No abstract available.
Beyond PEGylation.
Whelan J. Whelan J. Drug Discov Today. 2005 Mar 1;10(5):301. doi: 10.1016/S1359-6446(05)03387-8. Drug Discov Today. 2005. PMID: 15749275 No abstract available.
81,420 results
You have reached the last available page of results. Please see the User Guide for more information.